Related Experiment Videos
Fungal infections in AIDS patients
1Department of Medicine, Santa Clara Valley Medical Center, San Jose, California.
Abstract:
The mycoses are of increasing importance because of the AIDS epidemic. Oral and other forms of candidosis are nearly universal in AIDS patients. Cryptococcosis is the most common lethal mycosis, and may number tens of thousands of cases in AIDS worldwide annually. As the number of AIDS patients mounts, a rising tide of infections due to nearly all recognised fungal pathogens is occurring; examples include histoplasmosis, coccidioidomycosis and penicilliosis. These experiences have led to an investigation of new drugs which are compatible with the understanding that AIDS patients presently have an incurable underlying disease; that is, the drugs would be oral (allowing outpatient management) and/or have low toxicity, and may still be useful if only as a suppressive. These investigations have thus far focused on the triazoles. The current status of the mycoses and AIDS is reviewed.
Insights
The AIDS epidemic increases the importance of fungal infections (mycoses). New, low-toxicity oral antifungal drugs, like triazoles, are being investigated for managing these opportunistic infections in AIDS patients.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Immunocompromised Host
Background:
- The Acquired Immunodeficiency Syndrome (AIDS) epidemic has significantly increased the incidence and severity of fungal infections (mycoses).
- Opportunistic fungal infections, such as candidosis and cryptococcosis, are nearly universal or lethal in AIDS patients, posing a global health challenge.
- Rising numbers of AIDS cases correlate with an increase in various systemic mycoses, including histoplasmosis, coccidioidomycosis, and penicilliosis.
Purpose of the Study:
- To review the current status of mycoses in the context of the AIDS epidemic.
- To highlight the need for new antifungal therapies suitable for AIDS patients.
- To discuss the investigation of novel antifungal agents, particularly triazoles, for managing opportunistic fungal infections.
Main Methods:
- Literature review of mycoses in AIDS patients.
- Analysis of current treatment strategies and drug development efforts.
- Focus on antifungal drug characteristics: oral administration, low toxicity, and suppressive potential.
Main Results:
- Fungal infections are a major cause of morbidity and mortality in AIDS patients worldwide.
- The development of new antifungal drugs is crucial for managing these opportunistic infections.
- Triazoles are a primary focus for new drug development due to their favorable characteristics for AIDS management.
Conclusions:
- Effective management of mycoses in AIDS patients requires ongoing research into new antifungal therapies.
- Oral and low-toxicity antifungal agents are essential for outpatient and suppressive management.
- Continued investigation into triazoles and other antifungal classes is vital to combat the rising tide of fungal infections in the AIDS population.